244 related articles for article (PubMed ID: 31324555)
1. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease.
Dadar M; Miyasaki J; Duchesne S; Camicioli R
Parkinsonism Relat Disord; 2021 Apr; 85():95-101. PubMed ID: 33770671
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
[TBL] [Abstract][Full Text] [Related]
5. Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease.
Arena JE; Cerquetti D; Rossi M; Chaves H; Rollan C; Dossi DE; Merello M
Parkinsonism Relat Disord; 2016 Mar; 24():126-8. PubMed ID: 26823237
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort.
Kim R; Lee J; Kim Y; Kim A; Jang M; Kim HJ; Jeon B; Kang UJ; Fahn S
Parkinsonism Relat Disord; 2018 Jun; 51():49-54. PubMed ID: 29523394
[TBL] [Abstract][Full Text] [Related]
7. A 12-year population-based study of freezing of gait in Parkinson's disease.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
[TBL] [Abstract][Full Text] [Related]
8. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF
Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730
[TBL] [Abstract][Full Text] [Related]
9. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
10. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.
McKay JL; Nye J; Goldstein FC; Sommerfeld B; Smith Y; Weinshenker D; Factor SA
Neurobiol Dis; 2023 Apr; 179():106048. PubMed ID: 36813207
[TBL] [Abstract][Full Text] [Related]
11. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
[TBL] [Abstract][Full Text] [Related]
12. Microstructural changes in white matter associated with freezing of gait in Parkinson's disease.
Vercruysse S; Leunissen I; Vervoort G; Vandenberghe W; Swinnen S; Nieuwboer A
Mov Disord; 2015 Apr; 30(4):567-76. PubMed ID: 25640958
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
[TBL] [Abstract][Full Text] [Related]
14. Cerebral blood flow and freezing of gait in Parkinson's disease.
Imamura K; Okayasu N; Nagatsu T
Acta Neurol Scand; 2012 Sep; 126(3):210-8. PubMed ID: 22324564
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
[TBL] [Abstract][Full Text] [Related]
16. Freezing of gait in Parkinson's disease: gray and white matter abnormalities.
Pietracupa S; Suppa A; Upadhyay N; Giannì C; Grillea G; Leodori G; Modugno N; Di Biasio F; Zampogna A; Colonnese C; Berardelli A; Pantano P
J Neurol; 2018 Jan; 265(1):52-62. PubMed ID: 29128929
[TBL] [Abstract][Full Text] [Related]
17. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
18. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
Jeong SH; Lee HS; Jung JH; Baik K; Lee YH; Yoo HS; Sohn YH; Chung SJ; Lee PH
Mov Disord; 2021 Jun; 36(6):1411-1419. PubMed ID: 33513293
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
[TBL] [Abstract][Full Text] [Related]
20. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with parkinson's disease? A systematic review and meta-analysis.
Carvalho de Abreu DC; Pieruccini-Faria F; Son S; Montero-Odasso M; Camicioli R
Neurosci Biobehav Rev; 2024 Jun; 161():105677. PubMed ID: 38636832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
